Opportunities of precision medicine for triple-negative breast cancer / 中国肿瘤临床
Chinese Journal of Clinical Oncology
; (24): 1074-1077, 2016.
Article
in Chinese
| WPRIM (Western Pacific)
| ID: wpr-507819
Responsible library:
WPRO
ABSTRACT
Triple-negative breast cancer (TNBC) is a heterogeneous disease. Recently, the development of a gene expression profile fa-cilitated the re-classification of TNBC into six new subtypes, which show varied sensitivities to different therapies. In the era of preci-sion medicine, precision therapy may be directed at various potentially actionable molecular mutations in different subtypes of TNBC.
Full text:
Available
Database:
WPRIM (Western Pacific)
Language:
Chinese
Journal:
Chinese Journal of Clinical Oncology
Year:
2016
Document type:
Article